CATALYST FINANCIAL PARTNERS LLC
Position in DMAC — DiaMedica Therapeutics Inc.
CIK 1927537
BOSTON, MA
Position in DMAC
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$270,737
+$10,384 QoQ
Shares Held
38,457
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#32
of 87 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CATALYST FINANCIAL PARTNERS LLC holds $1,897,610 across 5 Biotechnology names. DMAC ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,320 | $655,683 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,725 | $510,338 | |
| 3 | DMAC |
DiaMedica Therapeutics Inc.
This page
|
38,457 | $270,737 | |
| 4 | ABOS |
Acumen Pharmaceuticals, Inc.
|
89,699 | $239,496 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
355 | $221,356 |
All Filings in DMAC
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $270,737 | 38,457 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $260,353 | 38,457 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $306,117 | 38,457 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $264,199 | 38,457 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $149,982 | 38,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $145,752 | 38,457 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $208,821 | 38,457 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $161,134 | 38,457 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $113,448 | 38,457 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $100,459 | 36,267 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $102,998 | 36,267 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $93,568 | 36,267 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $156,673 | 36,267 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $38,418 | 25,110 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $22,871 | 14,475 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||